Brijjit for Wound Closure in Gender Affirming Mastectomies
Are you eligible to participate in this study?
You may be eligible for this study if you meet the following criteria:
-
Conditions: Gender-affirming Mastectomy
-
Age: Between 18 years - 99 years
-
Gender: Male or Female
-
Other Inclusion Criteria:
- Participant self-identifies as Transgender or Gender Expansive
- Participant will undergo primary bilateral double incision mastectomy at NYULH
- All clinical criteria to be eligible for primary mastectomy must be met
- Ability to care for donor site and adhere to wound therapy (either solo or with care-giver assistance)
- Willingness to return for scheduled follow-up visits through 1 year post-operatively
- English Speaking
You may not be eligible for this study if the following are true:
-
- Individuals with previously diagnosed allergies or a history of adverse effects related to adhesives / adhesive tapes
- Individuals with a history of the following prescription medication use in the last year:
- Accutane
- Systemic glucocorticoids
- Local glucocorticoids or immunosuppressants (i.e. topical tacrolimus, topical clindamycin etc.) at the intervention site
- Individuals with a history of significant scarring or adverse scarring (hypertrophic scars or keloid scars)
- Individuals with pre-existing scars at the GAM wound closure site
- Individuals with a disorder known to negatively affect wound healing (i.e. autoimmune disease, connective tissue disease)
- Individuals with malnutrition
- Individuals with a BMI >30 kg/m2
- Individuals with a history of radiation therapy
- Active smokers or smokeless nicotine use
- History of Previous Mastectomy
- Participant is actively immunosuppressed i.e. AIDS (HIV+ acceptable), or Systemic immunosuppressants
- Participant unable to attend post-operative follow-ups in person
- Participant with a considerable history of medical non-compliance
- Participant is pregnant at time of operation
- Participant will receive GAM not including double incisions (i.e. periareolar)
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.